Evidence map›Paper›PMID 40724889›Full record

ArticleInternational journal of molecular sciences2025

Mycogenic Silver Nanoparticles: Promising Antimicrobials with Fungistatic Properties.

Aleksandra Tończyk, Katarzyna Niedziałkowska, Marta Nowak-Lange, Przemysław Bernat, Katarzyna Lisowska

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Biogenic Silver Nanoparticle: In vitro antifungal activity against Sporothrix brasiliensis.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aleksandra TończykDepartment of Industrial Microbiology and Biotechnology, Faculty of Biology and Environmental Protection, University of Lodz, 12/16 Banacha Street, 90-237 Lodz, Poland.ORCID 0000-0003-0510-1508
Katarzyna NiedziałkowskaDepartment of Industrial Microbiology and Biotechnology, Faculty of Biology and Environmental Protection, University of Lodz, 12/16 Banacha Street, 90-237 Lodz, Poland.ORCID 0000-0002-0785-4696
Marta Nowak-LangeDepartment of Industrial Microbiology and Biotechnology, Faculty of Biology and Environmental Protection, University of Lodz, 12/16 Banacha Street, 90-237 Lodz, Poland.ORCID 0000-0003-2345-4307
Przemysław BernatDepartment of Industrial Microbiology and Biotechnology, Faculty of Biology and Environmental Protection, University of Lodz, 12/16 Banacha Street, 90-237 Lodz, Poland.ORCID 0000-0002-5589-1555
Katarzyna LisowskaDepartment of Industrial Microbiology and Biotechnology, Faculty of Biology and Environmental Protection, University of Lodz, 12/16 Banacha Street, 90-237 Lodz, Poland.ORCID 0000-0001-6395-570X

Funding

Department of Industrial Microbiology and Biotechnology, Faculty of Biology and Environmental Sciences, University of Lodz B2411000000036.01
6 · The paper itself

Abstract

The antimicrobial activity of silver nanoparticles (AgNPs) makes them a valuable tool in various industries. Recently, biosynthesis has become the preferred method for nanoparticle synthesis, and among organisms that can be used as AgNP producers, filamentous fungi have attracted the greatest interest. In particular, wood decay fungi are considered promising candidates for AgNP biosynthesis. Biogenic AgNPs have been proven to have strong antibacterial potential and antifungal activity. The aim of this study was to evaluate the antifungal potential of AgNPs synthesized using the brown-rot decay fungus

Indexed as

Antifungal AgentsAnti-Infective AgentsFungiMetal NanoparticlesSilverAspergillus flavusCandida albicansCell MembraneMalasseziaMicrobial Sensitivity TestsAntifungal AgentsAnti-Infective AgentsSilverantifungalbiogeniccell membranefluiditylipidomepermeabilitysilver nanoparticles

Identifiers

PMID40724889
PMCPMC12294507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.